Overall survival by treatment
Two treatment arms of forty patients each as step curves, with a tick where a patient left the study, the 95% confidence bands and the number still at risk under the axis. The description gives every arm's events and median, the table the survival and the number at risk at every tick. Illustrative trial data, with a phone variant.
Overall survival by treatment
examples/overall-survival.json{
"schemaVersion": 1,
"type": "survival",
"title": "Overall survival by treatment",
"source": "Illustrative trial data, 40 patients per arm",
"width": 760,
"height": 520,
"survival": {
"groups": [
{
"label": "Standard",
"observations": [
{
"time": 8.4
},
{
"time": 14,
"event": false
},
{
"time": 9.9
},
{
"time": 2.9
},
{
"time": 13.9
},
{
"time": 1.4
},
{
"time": 1.3
},
{
"time": 1.3,
"event": false
},
{
"time": 28.9,
"event": false
},
{
"time": 14.9
},
{
"time": 0.5,
"event": false
},
{
"time": 1.8,
"event": false
},
{
"time": 3
},
{
"time": 0.4
},
{
"time": 8.1
},
{
"time": 10.3
},
{
"time": 9.7
},
{
"time": 8.3,
"event": false
},
{
"time": 29.9,
"event": false
},
{
"time": 21.2,
"event": false
},
{
"time": 5.3
},
{
"time": 2.1,
"event": false
},
{
"time": 12,
"event": false
},
{
"time": 11.6,
"event": false
},
{
"time": 25.4,
"event": false
},
{
"time": 0
},
{
"time": 14.1,
"event": false
},
{
"time": 11.9,
"event": false
},
{
"time": 1.1
},
{
"time": 8.1,
"event": false
},
{
"time": 1.3
},
{
"time": 22.7,
"event": false
},
{
"time": 1.8
},
{
"time": 1.5
},
{
"time": 5.3,
"event": false
},
{
"time": 11.5
},
{
"time": 3
},
{
"time": 2
},
{
"time": 1.7
},
{
"time": 3.4
}
]
},
{
"label": "New drug",
"observations": [
{
"time": 24.1,
"event": false
},
{
"time": 9.4
},
{
"time": 6.2
},
{
"time": 19.3,
"event": false
},
{
"time": 2.7
},
{
"time": 6.2
},
{
"time": 9.9,
"event": false
},
{
"time": 2.2,
"event": false
},
{
"time": 2.5
},
{
"time": 7.2
},
{
"time": 12.1
},
{
"time": 14.5,
"event": false
},
{
"time": 22.2
},
{
"time": 4.6,
"event": false
},
{
"time": 24.5,
"event": false
},
{
"time": 5.7,
"event": false
},
{
"time": 28.2,
"event": false
},
{
"time": 5.7
},
{
"time": 18.1,
"event": false
},
{
"time": 3.1,
"event": false
},
{
"time": 1
},
{
"time": 7.1
},
{
"time": 7.7
},
{
"time": 8.8,
"event": false
},
{
"time": 5
},
{
"time": 1.9
},
{
"time": 21.3
},
{
"time": 8.4,
"event": false
},
{
"time": 6.1,
"event": false
},
{
"time": 0.4
},
{
"time": 1.8,
"event": false
},
{
"time": 5
},
{
"time": 3.9,
"event": false
},
{
"time": 11.7
},
{
"time": 19.7,
"event": false
},
{
"time": 17.5,
"event": false
},
{
"time": 1.1,
"event": false
},
{
"time": 0.5
},
{
"time": 28.9,
"event": false
},
{
"time": 0.6
}
]
}
],
"confidence": true,
"timeTitle": "Months since randomization",
"logRank": true
},
"mobile": {
"width": 380,
"height": 560
}
}Source: Illustrative trial data, 40 patients per arm
Show chart data
| Group | Time | Survival | lower | upper | At risk |
|---|---|---|---|---|---|
| Standard | 0 | 97.5% | 83.5% | 99.6% | 40 |
| Standard | 10 | 46.7% | 29.5% | 62.2% | 14 |
| Standard | 20 | 29.7% | 13.7% | 47.6% | 5 |
| Standard | 30 | 29.7% | 13.7% | 47.6% | 0 |
| New drug | 0 | 100.0% | 100.0% | 100.0% | 40 |
| New drug | 10 | 52.5% | 34.1% | 68.0% | 13 |
| New drug | 20 | 44.4% | 26.3% | 61.1% | 6 |
| New drug | 30 | 29.6% | 11.6% | 50.3% | 0 |